[1]
Xu, T. 2024. Study and analysis of the use of bevacizumab in the treatment of breast cancer. Transactions on Materials, Biotechnology and Life Sciences. 7, (Dec. 2024), 749–758. DOI:https://doi.org/10.62051/xxztj722.